On-Demand HIV Pre-Exposure Prophylaxis
According to World Health Organization statistics, 1.7 million people became newly infected with HIV in 2019. Daily PrEP (pre-exposure prophylaxis) with the combination of emtricitabine (FTC) and tenofovir (TAF) or tenofovir disoproxil fumarate (TDF) is highly effective in preventing HIV infection. However, many people can find it challenging to adhere to a daily pill schedule and thus, may not fully benefit from PrEP.